Reckitt Benckiser Group plc (3RB.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR

Add to watchlist

77.30

-0.80

(-1.02%)

At close: 05:06PM CEST

Advertisement

Full screen

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	78.10
Open	78.10
Bid	77.30 x N/A
Ask	77.60 x N/A
Day's Range	77.30 - 78.10
52 Week Range	64.30 - 82.10
Volume	295
Avg. Volume	622

Market Cap	55.315B
Beta (5Y Monthly)	0.10
PE Ratio (TTM)	15.34
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	2.05 (2.60%)
Ex-Dividend Date	Aug 04, 2022
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for 3RB.F

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

All

News

Press Releases

Simply Wall St.
Should We Be Delighted With Reckitt Benckiser Group plc's (LON:RKT) ROE Of 34%?
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
- Are Robust Financials Driving The Recent Rally In Arvida Group Limited's (NZSE:ARV) Stock?
  Simply Wall St.
- Is Bioventix PLC's (LON:BVXP) Recent Stock Performance Influenced By Its Financials In Any Way?
  Simply Wall St.
The Wall Street Journal
Baby-Formula Startup Seeks Expansion as Shortage Persists
ByHeart is seeking to register two additional facilities with regulators to increase production as the U.S. continues to grapple with shortages.
Benzinga
Reckitt Lifts Annual Forecast On Higher Prices, Baby Formula Shortage
Reckitt Benckiser Group PLC (OTC: RBGLY) said Q2 like-for-like revenue rose 11.9% on a constant currency basis, beating the 6.8% growth analysts had expected in a company-supplied poll. Reckitt hiked prices 9.7% in the quarter, while sales volumes were up 2.2%. Q2 sales increased 5.9% on constant currency to £3.46 billion, including a 3.3% boost from sales of its Enfamil baby formula amid a shortage of supplies in the U.S. after Abbott Laboratories (NYSE: ABT) recalled dozens of brands in Februa